Canadian Immunization Guide Sixth Edition - 2002 292 Pages - (3,206 KB) in PDF Format Table of Contents Comparison of effects of diseases and vaccines Update to the 2002 Canadian Immunization Guide (2003-05-01)

- Message from the -
Assistant Deputy Minister
Population and Public Health Branch, Health Canada

All recommendations by the National Advisory Committee on Immunization (NACI) on the use of vaccines in Canada are contained in the Canadian Immunization Guide. A readership survey revealed that the Guide ranked as useful or better than other sources of information on immunization.

The Guide will also be available on the Centre for Infectious Disease Prevention and Control (CIDPC) Web site. Updates on NACI's new or revised recommendations are published in the Canada Communicable Disease Report (CCDR), which is also available on the web site.

If you have suggestions or comments on the Guide, we would be pleased to receive them for consideration for the next edition. You can send your comments to: Advisory Committee Secretariat, Immunization and Respiratory Infections Division, Centre for Infectious Disease Prevention and Control, P.L. 0603E1, Tunney's Pasture, Ottawa, Ontario K1A 0L2.

Producing such a publication requires considerable dedication and time on the part of those involved. We would like to thank the National Advisory Committee on Immunization; the responsible members of the Biologics and Genetic Therapies Directorate, Health Products and Food Branch, Health Canada; and the Centre for Infectious Disease Prevention and Control, Public Health Agency of Canada, and Health Canada, for producing this Guide.

- Preface -

The sixth edition of the Canadian Immunization Guide contains numerous changes from the 1998 version but attempts to remain user friendly. Every chapter has been thoroughly reviewed and updated as needed. New chapters have been added on varicella, Lyme disease and combined hepatitis A and B vaccines. Both the pneumococcal and meningococcal vaccine chapters have been expanded to include the new conjugate vaccines. The section on adverse events has been expanded. A chapter on communications with information about recommended web sites has also been added.

Highlights of some major changes in the Guide are as follows:

• varicella vaccine use during an outbreak and in health care workers;
• pneumococcal conjugate vaccine to prevent severe infection in children;
• meningococcal conjugate vaccine to help contain this feared disease;
• Lyme disease vaccine with limited use but helpful for those visiting endemic areas;
• the use of hepatitis A vaccine in outbreak management;
• the use of acellular pertussis vaccines for adolescents;
• internet sites of interest;
• talking with patients about immunization.

Changes in the Guide mirror the extraordinary pace of change in the immunization field. This pace has been challenging for members of the National Advisory Committee on Immunization (NACI), who worked for many hours to keep producing new statements while revising the Guide itself. I gratefully acknowledge the hard work and expert contributions of members of NACI, the Immunization and Respiratory Infections Division and other Centre for Infectious Disease Prevention and Control staff as well as the staff of the Biologics and Genetic Therapies Directorate. Important contributions were made by liaison members from the Canadian Association for Immunization Research and Evaluation, the Canadian Infectious Disease Society, the Canadian Paediatric Society, the College of Family Physicians of Canada, the Committee to Advise on Tropical Medicine and Travel, the Canadian Public Health Association, the Community and Hospital Infection Control Association, the Council of Chief Medical Officers of Health, National Defence and the National Immunization Programs, and the Centers for Disease Control and Prevention, United States Public Health Service. Close liaison with the US Advisory Committee on Immunization Practices has been invaluable.

Thanks go to the Groupe sur l'acte vaccinal (immunization standards group), Montreal, for its review of the French version of the Guide, to Dr. Stan Acres for his invaluable help in finalizing the document, and to Scientific Publication and Multimedia Services, Health Canada, for production.

Victor J.H. Marchessault
Chairman (1998 - )
National Advisory Committee on Immunization

- Preamble -

The National Advisory Committee on Immunization (NACI) provides Health Canada with ongoing and timely medical, scientific, and public health advice relating to immunization. Health Canada acknowledges that the advice and recommendations set out in this publication are based upon the best current available scientific knowledge, and is disseminating this document for information purposes. Persons administering or using the vaccines should also be aware of the contents of the relevant product monographs. Recommendations for use and other information set out herein may differ from that set out in the product monographs of the Canadian licensed manufacturers of the vaccines. Manufacturers have sought approval of the vaccines and provided evidence as to their safety and efficacy only when used in accordance with the product monographs.

- Table of Contents -

Part 1
General Considerations

part1-cdn_immuniz_guide-2002-6.pdf 54 Pages - (425 KB) in PDF Format

Cost Benefit General Cautions and Contraindications Adverse Events Anaphylactic Hypersensitivity to Egg and Egg-Related Antigens Anaphylaxis: Initial Management in Non-Hospital Settings Immunization During Pregnancy Immunization and Breast-Feeding Immunization of Children with Neurologic Disorders Immunization in Immunocompromised Hosts Immunization of People with Hemophilia and Other Bleeding Disorders Immunization of Infants Born Prematurely Timing of Vaccine Administration Recent Administration of Human Immune Globulin Products Storage and Handling of Immunizing Agents Immunization Technique Immunization Records Immunization of Children and Adults with Inadequate Immunization Records Talking with Patients About Immunization

Part 2
Recommended Immunization for Infants, Children and Adults

part2-cdn_immuniz_guide-2002-6.pdf 16 Pages - (169 KB) in PDF Format

A. Immunization Schedules for Infants and Children National Guidelines for Childhood Immunization Practices B. Immunization for Adults C. Opportunity for Immunization in Acute Care Institutions D. Immunization of Residents of Long-Term Care Institutions

Part 3
Active Immunizing Agents

part3-cdn_immuniz_guide-2002-6.pdf 171 Pages - (1,391 KB) in PDF Format

BCG Vaccine Cholera Vaccine Diphtheria Toxoid Haemophilus Vaccine Hepatitis A Vaccine Hepatitis B Vaccine Hepatitis Vaccines Combined Influenza Vaccine Japanese Encephalitis Vaccine Lyme Disease Vaccine Measles Vaccine Meningococcal Vaccine Mumps Vaccine Pertussis Vaccine Pneumococcal Vaccine Poliomyelitis Vaccine Rabies Vaccine Rubella Vaccine Smallpox Vaccine Tetanus Toxoid Typhoid Vaccine Varicella Vaccine Yellow Fever Vaccine

Part 4
Passive Immunizing Agents

part4-cdn_immuniz_guide-2002-6.pdf 9 Pages - (108 KB) in PDF Format

Immune Globulin (Human)     Measles     Hepatitis A     Rubella     Hepatitis C Safety of Immunoglobulin Preparations     Adverse Reactions     Contraindications     Precautions Specific Immune Globulins     Botulism antitoxin (equine)     Diphtheria antitoxin (equine)     Hepatitis B immune globulin (HBIG)     Rabies immune globulin (RIG)     Respiratory syncytical virus immune globulin intravenous (human) (RSV-IGIV)     Tetanus immune globulin (TIG)     Varicella-zoster immune globulin (VZIG)

Part 5
Immunization of Health Care Workers and Others Providing Personal Care

part5-cdn_immuniz_guide-2002-6.pdf 4 Pages - (63 KB) in PDF Format

Vaccines Recommended for all Health Care Workers Vaccines for Specific Risk Situations

Part 6
Immunization of Travellers

part6-cdn_immuniz_guide-2002-6.pdf 7 Pages - (82 KB) in PDF Format

Routine Immunizations Required Immunizations Recommended Immunizations Travellers Who are Immunodeficient or Infected with HIV Travellers Who are Pregnant Malaria Prophylaxis

Appendix I - Definitions Used for Reportable Adverse Events

app1-cdn_immuniz_guide-2002-6.pdf 3 Pages - (46 KB) in PDF Format

Appendix II - Report of a Vaccine-Associated Adverse Event

app2-cdn_immuniz_guide-2002-6.pdf 2 Pages - (972 KB) in PDF Format

Appendix III - Vaccine Products Available in Canada

app3-cdn_immuniz_guide-2002-6.pdf 5 Pages - (83 KB) in PDF Format

Appendix IV - Licensed Manufacturers or Distributors

app4-cdn_immuniz_guide-2002-6.pdf 2 Pages - (41 KB) in PDF Format

Index

index-cdn_immuniz_guide-2002-6.pdf 6 Pages - (81 KB) in PDF Format

Canadian Immunization Guide
Sixth Edition - 2002
292 Pages - (3,206 KB) in PDF Format